Kwality Pharmaceuticals Ltd (KPL) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1002639, "name": "Kwality Pharma", "stock_name": "Kwality Pharma", "full_name": "Kwality Pharmaceuticals Ltd", "name_url": "stocks-analysis/kwality-pharma", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "2,652.10", "chg": 93, "chgp": "3.63%", "dir": 1, "prev_price": "2,559.10", "mcapval": "2,731.00 Cr", "mcap": "Small Cap", "scripcode": 539997, "symbol": "KPL", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE552U01010", "curr_date": "Aug 06, 03:30 PM", "curr_time": "01:37 AM", "last_traded_at": "Aug 06, 03:30 PM IST", "bse_nse_vol": "34.22 k", "exc_status": "Active", "traded_date": "Aug 06, 2026", "traded_date_str": "2026 08 06", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kwality-pharma-1002639-1&utm_source=Spage_Header_Score", "mojoone": { "text": "Part of MojoOne Strategy", "type": "RP", "url": "https://www.marketsmojo.com/mojopro/strategy/3", "ismore": 0, "all_data": [], "is_blur": 1, "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kwality-pharma-1002639-1&utm_source=Spage_Score_PartofStrategies" } }, "news": { "results": [ { "title": "Kwality Pharmaceuticals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/kwality-pharmaceuticals-ltd-is-rated-hold-4137835", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/KwalityPharmace_mojoScore_4137835.png", "date": "2026-08-05 10:10:55", "description": "Kwality Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 03 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 August 2026, providing investors with an up-to-date perspective on the company’s performance and outlook." }, { "title": "Kwality Pharmaceuticals Ltd Sees Bullish Momentum Amid Technical Upgrades", "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-sees-bullish-momentum-amid-technical-upgrades-4137098", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/KwalityPharmace_technicaldot_4137098.png", "date": "2026-08-05 08:06:22", "description": "Kwality Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underpinned by a confluence of positive signals from key technical indicators, including MACD, Bollinger Bands, and moving averages, signalling renewed investor interest despite mixed short-term returns relative to the broader market." }, { "title": "When is the next results date for Kwality Pharmaceuticals Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-kwality-pharmaceuticals-ltd-4136445", "imagepath": "", "date": "2026-08-04 23:19:30", "description": "The next results date for Kwality Pharmaceuticals Ltd is scheduled for 10 August 2026...." }, { "title": "Kwality Pharmaceuticals Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-sees-technical-momentum-shift-amid-mixed-indicator-signals-4135186", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/KwalityPharmace_technicaldot_4135186.png", "date": "2026-08-04 08:09:08", "description": "Kwality Pharmaceuticals Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish trend. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock’s mixed technical indicators suggest a complex outlook for investors navigating current market conditions." }, { "title": "Kwality Pharmaceuticals Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/kwality-pharmaceuticals-ltd-is-rated-buy-4120169", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/KwalityPharmace_mojoScore_4120169.png", "date": "2026-07-25 10:10:28", "description": "Kwality Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 13 July 2026. However, the analysis and financial metrics discussed here reflect the company's current position as of 25 July 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Kwality Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-technical-momentum-shifts-signal-bullish-outlook-4108529", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/KwalityPharmace_technicaldot_4108529.png", "date": "2026-07-20 08:03:31", "description": "Kwality Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bullish to a more confident bullish stance. Despite a recent 4.00% dip in the stock price to ₹2,699.05, the underlying technical framework suggests strengthening momentum that could favour investors in the Pharmaceuticals & Biotechnology sector." }, { "title": "Kwality Pharmaceuticals Gains 4.00%: 2 Key Factors Driving the Move", "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-gains-400-2-key-factors-driving-the-move-4107300", "imagepath": "", "date": "2026-07-18 13:02:37", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>13 Jul:</strong> Stock opens at Rs.2,657.20 with a 2.39% gain</p>\n <p><strong>14 Jul:</strong> Upgraded to Buy on strong financials and bullish technicals</p>\n <p><strong>16 Jul:</strong> Technical momentum shifts amid strong returns, stock hits Rs.2,811.45 (+3.80%)</p>\n <p><strong>17 Jul:</strong> Week closes at Rs.2,699.05 (-4.00%) despite Sensex gains</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,595.25</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close..." }, { "title": "Kwality Pharmaceuticals Ltd Sees Technical Momentum Shift Amid Strong Returns", "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-sees-technical-momentum-shift-amid-strong-returns-4104468", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/KwalityPharmace_technicaldot_4104468.png", "date": "2026-07-16 08:03:21", "description": "Kwality Pharmaceuticals Ltd has demonstrated robust price momentum with a 2.66% gain on 16 Jul 2026, closing at ₹2,708.45, signalling renewed investor interest despite mixed technical indicator readings. The stock’s recent upgrade from Hold to Buy by MarketsMOJO, alongside a Mojo Score of 70.0, reflects growing confidence in its medium-term prospects within the Pharmaceuticals & Biotechnology sector." }, { "title": "Kwality Pharmaceuticals Upgraded to Buy on Strong Financials and Bullish Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/kwality-pharmaceuticals-upgraded-to-buy-on-strong-financials-and-bullish-technicals-4100347", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/KwalityPharmace_mojoScore_4100347.png", "date": "2026-07-14 09:02:44", "description": "Kwality Pharmaceuticals Ltd has seen its investment rating upgraded from Hold to Buy, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, effective from 13 July 2026, underscores the company’s robust quarterly results, sustained returns, and bullish technical signals that have captured investor attention in the Pharmaceuticals & Biotechnology sector." } ], "total": 320, "sid": "1002639", "stock_news_url": "https://www.marketsmojo.com/news/kwality-pharmaceuticals-1002639" }, "announcements": "", "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "10 Aug 2026" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Kwality Pharmaceuticals Ltd has declared <strong>6%</strong> dividend, ex-date: 05 Jan 17", "dt": "2017-01-05", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Kwality Pharmaceuticals Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 11 Oct 17", "dt": "2017-10-11", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

13 Jul: Stock opens at Rs.2,657.20 with a 2.39% gain

14 Jul: Upgraded to Buy on strong financials and bullish technicals

16 Jul: Technical momentum shifts amid strong returns, stock hits Rs.2,811.45 (+3.80%)

17 Jul: Week closes at Rs.2,699.05 (-4.00%) despite Sensex gains

Week Open

Rs.2,595.25

Week Close...

Read full news article

Kwality Pharmaceuticals Ltd Sees Technical Momentum Shift Amid Strong Returns

2026-07-16 08:03:21

Kwality Pharmaceuticals Ltd has demonstrated robust price momentum with a 2.66% gain on 16 Jul 2026, closing at ₹2,708.45, signalling renewed investor interest despite mixed technical indicator readings. The stock’s recent upgrade from Hold to Buy by MarketsMOJO, alongside a Mojo Score of 70.0, reflects growing confidence in its medium-term prospects within the Pharmaceuticals & Biotechnology sector.

Read full news article

Kwality Pharmaceuticals Upgraded to Buy on Strong Financials and Bullish Technicals

2026-07-14 09:02:44

Kwality Pharmaceuticals Ltd has seen its investment rating upgraded from Hold to Buy, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, effective from 13 July 2026, underscores the company’s robust quarterly results, sustained returns, and bullish technical signals that have captured investor attention in the Pharmaceuticals & Biotechnology sector.

Read full news article